Updates

October 14, 2019October 14, 2019
Ankylosing Spondylitis Psoriasis, Axial Psoriatic Arthritis Unrelated, Study Says

Psoriasis in ankylosing spondylitis (AS) patients is not related to axial psoriatic arthritis (PsA), a type of psoriasis causing lower back inflammation and ... Read more
October 10, 2019October 10, 2019
Anti-TNF Therapy Slows Down AS Progression and Bone Loss, Study Says

Anti-TNF therapies can halt disease progression and bone loss, and are associated with clinical improvement in people with ankylosing spondylitis after one year ... Read more
October 7, 2019October 7, 2019
Cosentyx Effectively Lowers Disease Activity in nr-axSpA Patients Treated for 1 Year, Phase 3 Trial Reports

Treatment with Novartis’ Cosentyx (secukinumab) significantly reduced disease activity compared to placebo in patients with non-radiographic axial spondyloarthritis (nr-axSpA), according to new data ... Read more
October 3, 2019October 3, 2019
AS Patients at Greater Risk of Other Inflammatory Diseases, Taiwanese Study Reports

People with ankylosing spondylitis (AS) are at a greater risk of developing certain inflammatory diseases — specifically, Behcet’s disease, Buerger’s disease, acute anterior uveitis, sarcoidosis, ... Read more
October 2, 2019September 27, 2019
Anger Is a Natural Response to Chronic Illness

I’ve kept this column positive for a while now, not only for you, my readers, but also for myself. If I keep my head ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

News

Heat Therapy Called Moxibustion May Help People with Ankylosing Spondylitis, Short-term Study Finds
September 30, 2019September 30, 2019
Moxibustion, a form of heat therapy widely used in East Asia, given in combination ...
News

NORD 2019 Rare Disease Summit Set for Oct. 21-22 in Washington, DC
September 26, 2019
Next month’s annual conference of the National Organization for Rare Disorders (NORD) in Washington, ...
News

Depression More Common in People with Ankylosing Spondylitis, Analysis Shows
September 26, 2019September 26, 2019
Depression is more common among people with ankylosing spondylitis (AS) than in the general ...
A Wellness Journey - a Column by Lisa Marie Basile, Columns

Canceling on Friends: The Good, the Bad, and the Ugly
September 25, 2019September 30, 2019
It’s easy to say that if people can’t understand us, we should just forget ...
News

Cosentyx Shows Promise in Managing nr-axSpA Disease Activity, Phase 3 Trial Shows
September 23, 2019September 23, 2019
Treatment with Novartis’ Cosentyx (secukinumab) led to a significant reduction in disease activity compared to placebo in ...
News

Diffusion-weighted Imaging Useful to Identify Axial Spondyloarthritis
September 19, 2019September 19, 2019
A specific type of MRI called diffusion-weighted imaging is sensitive enough to identify patients ...

Biosimilar to Humira, IBI303, Shows Comparable Efficacy and Safety in Phase 3 Trial in China
September 16, 2019September 16, 2019
Treating ankylosing spondylitis (AS) patients with Humira (adalimumab) or a potential biosimilar called IBI303 had comparable ...
Qigong May Reduce AS Patients’ Fatigue, Morning Stiffness, Study Suggests
September 9, 2019September 9, 2019
Baduanjin qigong training, a traditional Chinese exercise, may reduce fatigue and morning stiffness in ...
FDA Approves Lilly’s Taltz for the Treatment of Active Ankylosing Spondylitis
September 5, 2019September 5, 2019
At NY Genome Center, Legal Expert Presents Ethical Dilemmas in Gene Editing
September 5, 2019
‘Disorder’ Film Festival Offers Look at Siblings Touched by Rare Diseases
September 2, 2019August 30, 2019
Pilates Training May Be Beneficial for AS Patients, Study Finds
August 29, 2019August 29, 2019

Almost Half of AS Patients May Experience Mild Hearing Loss, Study Suggests
August 26, 2019August 26, 2019
Mild hearing loss is common among people with ankylosing spondylitis, particularly in older patients ...
AS Places Large Financial Burden on German Healthcare System, Study Finds
August 22, 2019August 22, 2019
Nebraska’s Neena Nizar Seeks Cure for Jansen’s, One of World’s Rarest Diseases
August 19, 2019August 19, 2019
Tonsillitis May Predispose People to Ankylosing Spondylitis, Study Suggests
August 12, 2019August 12, 2019

Yisaipu, Biosimilar of Enbrel, Will be Available as Pre-filled Syringe in China
August 5, 2019August 5, 2019
Yisaipu, a biosimilar of Enbrel (etanercept), has been approved in China as a pre-filled ...
Rare Disease Groups Seek Public Support to Renew Newborn Screening Act in Senate
August 1, 2019
Oklahoma Ranks Lowest on Programs Key to Rare Diseases on NORD’s 2019 State Report Card
August 1, 2019

News

Patients at Higher Risk of Self-Harm After Ankylosing Spondylitis Diagnosis, Study Finds
August 1, 2019August 1, 2019
Self-harm is more common in people diagnosed with ankylosing spondylitis compared with the general ...
News

FDA Approves Humira Biosimilar Hadlima for Treatment of Ankylosing Spondylitis
July 29, 2019July 29, 2019
Hadlima (adalimumab-bwwd), a biosimilar to AbbVie’s Humira, has been approved by the U.S. Food ...
News

Italian Analysis Finds Cosentyx Is Cost-effective for AS, Other Conditions
July 25, 2019July 25, 2019
In Italy, Cosentyx (secukinumab) is a cost-saving treatment for ankylosing spondylitis, as well as ...
A Wellness Journey - a Column by Lisa Marie Basile, Columns

Here Are Some Inspiring AS Instagram Accounts to Follow
July 24, 2019July 22, 2019
When you’re searching for others who understand the AS experience, you probably want to ...
News

Hip, Knee Replacement Surgeries More Frequent in Older AS Patients than the General Population
July 22, 2019July 22, 2019
Total hip replacement surgery, or hip arthroplasty, has doubled in older patients with ankylosing ...
News

European Initiative Targets Diagnosis, Treatment of Rare Diseases
July 18, 2019July 18, 2019
A new international consortium based in Paris, and funded largely by the 28-member European ...

March 7, 2018March 7, 2018

Cosentyx Leads to Long-Term Improvement in AS Patients, Phase 3 Trial Shows

News

Results from a Phase 3 clinical trial show that treatment with Cosentyx (secukinumab) led to fast, significant, and sustained symptom improvement in patients with active ankylosing spondylitis (AS). Improvements were particularly noticeable in patients who had never ... Read more

Subscribe to our mailing list

Pin It on Pinterest